Childhood Hodgkin lymphoma survivors have increased risk of developing various types of solid tumors in the future. However, recent research has found specific sub-groups of patients especially have an elevated risk. These findings could help refine guidelines for screening of cancer in Hodgkin lymphoma survivors.
It's known that survivors of Hodgkin lymphoma--a cancer that starts in cells called lymphocytes--during childhood have an increased risk of developing additional forms of cancer, including solid cancers, but the magnitude of this risk over the long term is unknown.
Hodgkins Lymphoma
Hodgkins lymphoma or Hodgkins disease has the distinction of being the first cancer to be cured by chemotherapy or by radiotherapy.
Advertisement
‘Certain subgroups of childhood Hodgkin lymphoma survivors are at high risk of developing new solid cancers such as breast cancer, colorectal cancer and thyroid cancer.’
Tweet it Now
To investigate, Smita Bhatia, MD, MPH, of the University of Alabama at Birmingham, and her colleagues analyzed information on 1,136 patients who were diagnosed with Hodgkin lymphoma before age 17 years between 1955 and 1986. Over a median length of follow-up of 26.6 years, 162 individuals developed solid cancers. The researchers determined that the survivors had a 14-fold increased risk of developing cancer compared with the general population. They also noted that the cumulative incidence of any solid cancer was 26.4 percent at 40 years after a Hodgkin lymphoma diagnosis.
Risk factors for breast cancer among females were Hodgkin lymphoma diagnosis between 10 and 16 years of age and chest radiation. Males treated with chest radiation before 10 years of age were at highest risk for lung cancer. Hodgkin lymphoma survivors treated with abdominal/pelvic radiation and high-dose alkylating agents were at highest risk for colorectal cancer, and females exposed to neck radiation before 10 years of age were at highest risk for thyroid cancer. By age 50 years, the cumulative incidence of breast, lung, colorectal, and thyroid cancer was 45.3 percent, 4.2 percent, 9.5 percent, and 17.3 percent, respectively, among those at highest risk.
![Non-Hodgkins Lymphoma]( "Non-Hodgkins Lymphoma")
Non Hodgkins Lymphoma is a cancer that affects the lymph tissues. It is made up of a wide array of subtypes.
"This large multi-institutional, international cohort of childhood Hodgkin lymphoma allowed us to determine the risk of new solid cancers such as breast cancer, colorectal cancer and thyroid cancer," said Dr. Bhatia. "More importantly, we were able to use host and clinical characteristics to identify subgroups of Hodgkin lymphoma survivors who were particularly vulnerable to developing these new cancers." She noted that these findings could be useful for developing screening strategies for individual survivors.
"As a physician and a childhood Hodgkin lymphoma survivor who developed radiation-related breast cancer 34 years after treatment, I cannot emphasize enough the importance of these data for the long-term care of survivors, as they not only underscore the necessity of lifelong cancer screening in that population, but also provide a stratification of risk for specific malignancies within subgroups, allowing for a more targeted approach to screening," said Allison Thompson-Graves, MD, who was not involved with the study.
Source: Eurekalert
Non-Hodgkins Lymphoma
Non Hodgkins Lymphoma is a cancer that affects the lymph tissues. It is made up of a wide array of subtypes.
Advertisement
"This large multi-institutional, international cohort of childhood Hodgkin lymphoma allowed us to determine the risk of new solid cancers such as breast cancer, colorectal cancer and thyroid cancer," said Dr. Bhatia. "More importantly, we were able to use host and clinical characteristics to identify subgroups of Hodgkin lymphoma survivors who were particularly vulnerable to developing these new cancers." She noted that these findings could be useful for developing screening strategies for individual survivors.
"As a physician and a childhood Hodgkin lymphoma survivor who developed radiation-related breast cancer 34 years after treatment, I cannot emphasize enough the importance of these data for the long-term care of survivors, as they not only underscore the necessity of lifelong cancer screening in that population, but also provide a stratification of risk for specific malignancies within subgroups, allowing for a more targeted approach to screening," said Allison Thompson-Graves, MD, who was not involved with the study.
Source: Eurekalert
Burkitt’s Lymphoma
Burkitt's lymphoma is a rare type of non-hodgkin's lymphoma that commonly affects children. It usually begins in the abdominal region.
Advertisement
 Follicular LymphomaFollicular lymphoma is a slow growing cancer of the lymph nodes. It is the most common form of slow growing B-cell non-Hodgkin's lymphoma. | Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The new study uncovers the efficacy of fixed-duration combination treatment in patients with high-risk leukemia.
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable